MicroRNA-302b Negatively Regulates IL-1β Production in Response to MSU Crystals by Targeting IRAK4 and EphA2
Overview
Authors
Affiliations
Background: Interleukin-1β (IL-1β) is a pivotal proinflammatory cytokine that is strongly associated with the inflammation of gout. However, the underlying mechanism through which the production of IL-1β is regulated has not been fully elucidated. Our previous work identified that miR-302b had an important immune regulatory role in bacterial lung infections. This study was conducted to evaluate the function of miR-302b on monosodium urate (MSU) crystal-induced inflammation and its mechanism.
Methods: The expression pattern and the immune-regulatory role of miR-302b were evaluated both in vitro and in vivo. The functional targets of miR-302b were predicted by bioinformatics, and then validated by genetic approaches. In addition, the clinical feature of miR-302b was analyzed using serum samples of patients with gouty arthritis.
Results: The extremely high expression of miR-302b was observed in both macrophages and mouse air membranes treated with MSU. Intriguingly, overexpression of miR-302b regulated NF-κB and caspase-1 signaling, leading to significantly attenuate MSU-induced IL-1β. By genetic analysis, miR-302b exhibited inhibitory function on IRAK4 and EphA2 by binding to their 3'-UTR regions. Corporately silencing IRAK4 and EphA2 largely impaired MSU-induced IL-1β protein production. Moreover, it was also found that miR-302b and EphA2 suppressed the migration of macrophages. Finally, it was observed that high expression of miR-302b was a general feature in patients with gouty arthritis.
Conclusions: These results suggest that miR-302b can regulate IL-1β production in MSU-induced inflammation by targeting NF-κB and caspase-1 signaling, and may be a potential therapeutic target for gouty arthritis.
Perspectives in MicroRNA Therapeutics for Cystic Fibrosis.
Finotti A, Gambari R Noncoding RNA. 2025; 11(1.
PMID: 39846681 PMC: 11755495. DOI: 10.3390/ncrna11010003.
Mechanism of macrophages in gout: Recent progress and perspective.
Tan H, Zhang S, Liao J, Qiu X, Zhang Z, Wang Z Heliyon. 2024; 10(19):e38288.
PMID: 39386881 PMC: 11462003. DOI: 10.1016/j.heliyon.2024.e38288.
Mancuso R, Citterio L, Agostini S, Marventano I, La Rosa F, Re F Pharmaceuticals (Basel). 2023; 16(11).
PMID: 38004455 PMC: 10675475. DOI: 10.3390/ph16111590.
Sirt3 improves monosodium urate crystal-induced inflammation by suppressing Acod1 expression.
Lv L, Jiang H, Song D, Zhou X, Chen F, Ren L Arthritis Res Ther. 2023; 25(1):121.
PMID: 37468929 PMC: 10354977. DOI: 10.1186/s13075-023-03107-6.
Balahura Stamat L, Dinescu S, Costache M Int J Mol Sci. 2023; 24(4).
PMID: 36834660 PMC: 9963301. DOI: 10.3390/ijms24043245.